Current controversies in prenatal diagnosis 4: Pre-conception expanded carrier screening should replace all current prenatal screening for specific single gene disorders

Prenatal Diagnosis

Volumn 35, Issue 1, 2015, Pages 23-28

  Langlois, Sylvie ^a   Benn, Peter ^b   Wilkins Haug, Louise ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; ETHNIC GROUP; ETHNICITY; FAMILY HISTORY; GENE MUTATION; GENETIC COUNSELING; GENETIC DISORDER; GENETIC VARIABILITY; HEMOGLOBINOPATHY; HETEROZYGOTE; HUMAN; MEDICAL ETHICS; MEDICAL TECHNOLOGY; MEDICOLEGAL ASPECT; NEWBORN; NEWBORN SCREENING; PRACTICE GUIDELINE; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCREENING; UNITED STATES; ETHICS; FEMALE; GENETIC DISEASES, INBORN; HETEROZYGOTE DETECTION; PREGNANCY; PROCEDURES;

FEMALE; GENETIC DISEASES, INBORN; HETEROZYGOTE DETECTION; HUMANS; INFANT, NEWBORN; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84921452750     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4532     Document Type: Article

References (33)

1. Kaback, MM. Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model. Eur J Pediatr 2000;159:S192-5.
2. Cao A, Furbetta M, Galanello R, et al. Prevention of homozygous beta-thalassemia by carrier screening an prenatal diagnosis in Sardinia. Am J Hum Genet 1981;33:592-605.
3. Fessas P. Prevention of thalassemia and hemoglobin S syndromes in Greece. Acta Haematol 1987;78:168-72.
4. Grody WW, Cutting GR, Klinger KW, et al. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Subcommittee on Cystic Fibrosis Screening. Accreditation of Genetic Services Committee, ACMG. American College of Medical Genetics. Genet Med 2001;3:149-54.
5. ACOG. American College of Obstetricians and Gynecologists Committee on Genetics. ACOG Committee Opinion 46. Update on carrier screening for cystic fibrosis. Obstetr Gynecol 2011;117:1028-31.
6. Human Genetics Society of Australasia. Cystic fibrosis population screening position paper (Document 2013PS03). HGSA: Sydney, Australia. http://www.hgsa.org.au/documents/item/1282. Accessed September 15, 2014.
7. Wilson RD, Davies G, Desilets V, et al. Cystic fibrosis carrier testing in pregnancy in Canada. J Obstet Gynaecol Can 2002;24:644-51.
8. UK National Screening Committee. Cystic fibrosis (pregnancy). UK NSC Policy database. http://www.screening.nhs.uk/cysticfibrosis-pregnancy. Accessed September 15, 2014.
9. Prior TW, Professional Practice and Guidelines Committee. Carrier screening for spinal muscular atrophy. Genet Med 2008; 10:840-2.
10. ACOG Committee on Genetics. ACOG committee opinion No. 432: spinal muscular atrophy. Obstet Gynecol 2009;113:1194-6.
11. Beaudet AL, Scriver CR, Sly WS, Valle D. Chapter 1. Genetics, Biochemistry, and Molecular Bases of Variant Human Phenotypes. In, Metabolic and Molecular Basis of Human Disease. Valle D, Beaudet AL, Vogelstein B, et al. McGraw-Hill: NewYork. http://www.ommbid.com/OMMBID/a/c.html/introduction/genetics_biochemistry_molecular_bases_variant_human_phenotypes. Accessed 07/28/2014.
12. Bajaj, K, Gross SJ. Carrier screening: past, present, and future. J Clin Med 2014;3:1033-42.
13. Hoppe CC. Prenatal and newborn screening for hemoglobinopathies. Internal J Lab Hematol 2013;35:297-305.
14. California Newborn Screening Program. http://www.cdph.ca.gov/programs/nbs/Pages/NBSHowCommon.aspx. Accessed 7/28/2014.
15. Passel, JS, Wang W, Taylor P. Marrying Out. One-in-Seven New U.S. Marriages Is Interracial or Interethnic. Pew Social Trends. June, 15; 2010. http://pewsocialtrends.org/files/2010/10/755-marrying-out.pdf. Accessed 07/28/2014.
16. United Jewish Communities Report. National Jewish Population Survey, 2000-2001. http://www.jewishdatabank.org/Studies/downloadFile.cfm?FileID=1490. Accessed 07/28/2014.
17. Lazarin GA, Haque IS, Nazareth S, et al. An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23, 453 individuals. Genet Med 2013;15:178-86.
18. Ross LF. A re-examination of the use of ethnicity in prenatal carrier testing. Am J Med Genet Part A 2011;158A:19-23.
19. Hallam S, Nelson H, Greger V et al., Validation for clinical use of, and initial clinical experience with, a novel approach to population-based carrier screening using high-throughput, next-generation DNA sequencing. J Mol Diagn 2014;16:180-9.
20. Bell CJ, Dinwiddie DL, Miller NA, et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Translat Med 2011;3:65ra4.
21. Kingsmore S. Comprehensive carrier screening and molecular diagnostic testing for recessive childhood diseases. PLoS Curr. 2012:e4f9877ab8ffa9.
22. Grody WW, Thompson BH, Gregg AR, et al. ACMG position statement on prenatal/preconception expanded carrier screening. Genet Med 2013;15:482-3.
23. Mosher WD, Jones J, Abma JC. Intended and unintended births in the United States: 1982-2010. Natl Health Stat Report 2012 Jul 24;(55):1-28.
24. ACOG 2009.
25. Morgan MA, Driscoll DA, Mennuti MT, et al. Practice patterns of obstetrician-gynecologists regarding preconception and prenatal screening for cystic fibrosis. Genet Med 2004;6:450-5.
26. Benn P, Chapman AR, Erickson K, et al. Obstetricians and gynecologists' practice and opinions of expanded carrier testing and noninvasive prenatal testing. Prenat Diagn 2014;34:145-52.
27. Strom CM, Redman JB, Peng M. The dangers of including nonclassical cystic fibrosis variants in population-based screening panels: p.L997F, further genotype/phenotype correlation data. Genet Med 2011;13:1042-4.
28. Rohlfs EM, Zhou Z, Heim RA, et al. Cystic fibrosis carrier testing in an ethnically diverse US population. Clin Chem 2011;57:841-8.
29. Traeger-Synodinos J, Harteveld CL, Old JM, et al. EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies. Eur J Hum Genet 2014 Jul 23. doi:10.1038/ejhg.2014.131.
30. Minkoff H, Berkowitz R. The case for universal prenatal genetic counseling. Obstet Gynecol 2014;123:1335-8.
31. Cho D, McGowan ML, Metcalfe J, et al. Expanded carrier screening in reproductive healthcare: perspectives from genetics professionals. Hum Reprod 2013;28:1725-30.
32. Stoll K, Resta R. Considering the cost of expanded carrier screening panels. Genet Med 2013;15:318-9.
33. McGowan ML, Cho D, Sharp RR. The changing landscape of carrier screening:expanding technology and options? Health Matrix Clevel 2013;23:15-33.